How we treat HER2-positive brain metastases
Sign Up to like & getrecommendations! Published in 2021 at "ESMO Open"
DOI: 10.1016/j.esmoop.2021.100256
Abstract: Overexpression of the human epidermal growth factor 2 (HER2)/neu glycoprotein receptor in breast cancer is associated with increased risk of brain metastases, especially in patients with advanced disease. Improvements in the treatment of HER2-positive breast… read more here.
Keywords: brain metastases; her2 positive; treat her2; positive brain ... See more keywords
To treat or not to treat: HER2 equivocal is the matter!
Sign Up to like & getrecommendations! Published in 2018 at "Translational cancer research"
DOI: 10.21037/16010
Abstract: With the introduction of the 2013 American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines for human epidermal growth factor receptor type 2 (HER2) testing, some authors noticed an increase in equivocal HER2… read more here.
Keywords: her2 equivocal; treat; treat treat; equivocal matter ... See more keywords
How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story
Sign Up to like & getrecommendations! Published in 2022 at "Life"
DOI: 10.3390/life12030378
Abstract: CDK4/6 inhibitors in association with endocrine therapy represent the best therapeutic choice for either endocrine-sensitive or resistant hormone-receptor-positive advanced breast cancer patients. On the contrary, the optimal therapeutic strategy after the failure of CDK4/6 inhibitors-based… read more here.
Keywords: breast cancer; treat her2; cdk4 inhibitors; cancer patients ... See more keywords